Lisa M Pitchford
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial.Zachary T Yoneda, Matthew O'Neill, Diane M Crawford
|Dec 19, 2024
International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB).John A Rathmacher, Lisa M Pitchford, Jeffrey R Stout
|Nov 02, 2024
Impaired suppression of fatty acid release by insulin is a strong predictor of reduced whole-body insulin-mediated glucose uptake and skeletal muscle insulin receptor activation.Michael W Schleh, Benjamin J Ryan, Cheehoon Ahn
|Mar 29, 2023
Metabolic dysfunction in obesity is related to impaired suppression of fatty acid release from adipose tissue by insulin.Michael W Schleh, Benjamin J Ryan, Cheehoon Ahn
|Jan 08, 2020
Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial.Lisa M Pitchford, Patricia M Driver, John C Fuller
|Jan 07, 2019
First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers.Lisa M Pitchford, John A Rathmacher, John C Fuller
Pageof 1
Frequent Collaborators
2 joint publications
Michael W Schleh
2 joint publications
Benjamin J Ryan
2 joint publications
Cheehoon Ahn
2 joint publications
Alison C Ludzki
2 joint publications
Jeffrey F Horowitz
2 joint publications
John A Rathmacher
1 joint publications
Douglas W Van Pelt
1 joint publications
Scott L Hummel
1 joint publications
Austin T Luker
1 joint publications
Kathryn E Luker
